Be the first to like this
Complete report is available @ http://www.reportsnreports.com/reports/239426-outsourced-ion-channel-testing-trends-2013.html .
• The main objectives were to comprehensively document current use of and potential interest in outsourcing ion channel primary screening, selectivity profiling and safety liability testing. The survey also investigated access to and future purchasing of stably transfected ion channel cell lines.
• Equal emphasis was given to soliciting opinion from Pharma, Biotech and Academic Research segments, mainly in North America and Europe.
• The survey looked at the following aspects of outsourced ion channel testing, as practiced to date (2013) and in some cases as predicted for the future (2015): current targeting of ion channels as therapeutic targets using primary screening; number of on-going screening programs with ion channels as a therapeutic target